Case and Research Letter
Relapse of morphea during Nivolumab therapy for lung adenocarcinoma
Recaída de morfea durante tratamiento con Nivolumab en adenocarcinoma de pulmón
A. Alegre-Sánchez
, P. Fonda-Pascual, D. Saceda-Corralo, E. de las Heras-Alonso
Autor para correspondencia
Dermatology Service, Ramon y Cajal Hospital, Madrid, Spain
Leído
5414
Vecesse ha leído el artículo
2413
Total PDF
3001
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 43 | 19 | 62 |
| 2025 5 | 75 | 27 | 102 |
| 2025 4 | 74 | 31 | 105 |
| 2025 3 | 78 | 20 | 98 |
| 2025 2 | 74 | 34 | 108 |
| 2025 1 | 48 | 21 | 69 |
| 2024 12 | 40 | 24 | 64 |
| 2024 11 | 49 | 65 | 114 |
| 2024 10 | 36 | 35 | 71 |
| 2024 9 | 35 | 20 | 55 |
| 2024 8 | 49 | 34 | 83 |
| 2024 7 | 46 | 34 | 80 |
| 2024 6 | 50 | 31 | 81 |
| 2024 5 | 41 | 34 | 75 |
| 2024 4 | 52 | 23 | 75 |
| 2024 3 | 40 | 27 | 67 |
| 2024 2 | 31 | 23 | 54 |
| 2024 1 | 33 | 29 | 62 |
| 2023 12 | 26 | 19 | 45 |
| 2023 11 | 48 | 27 | 75 |
| 2023 10 | 43 | 20 | 63 |
| 2023 9 | 40 | 30 | 70 |
| 2023 8 | 25 | 12 | 37 |
| 2023 7 | 51 | 31 | 82 |
| 2023 6 | 28 | 20 | 48 |
| 2023 5 | 43 | 20 | 63 |
| 2023 4 | 36 | 23 | 59 |
| 2023 3 | 51 | 21 | 72 |
| 2023 2 | 39 | 19 | 58 |
| 2022 1 | 27 | 25 | 52 |
| 2022 12 | 48 | 25 | 73 |
| 2022 11 | 34 | 35 | 69 |
| 2022 10 | 53 | 27 | 80 |
| 2022 9 | 27 | 51 | 78 |
| 2022 8 | 37 | 50 | 87 |
| 2022 7 | 33 | 57 | 90 |
| 2022 6 | 29 | 26 | 55 |
| 2022 5 | 26 | 35 | 61 |
| 2022 4 | 35 | 33 | 68 |
| 2022 3 | 41 | 49 | 90 |
| 2022 2 | 26 | 30 | 56 |
| 2021 1 | 46 | 46 | 92 |
| 2021 12 | 39 | 48 | 87 |
| 2021 11 | 33 | 46 | 79 |
| 2021 10 | 45 | 53 | 98 |
| 2021 9 | 36 | 38 | 74 |
| 2021 8 | 38 | 42 | 80 |
| 2021 7 | 29 | 39 | 68 |
| 2021 6 | 42 | 40 | 82 |
| 2021 5 | 36 | 38 | 74 |
| 2021 4 | 69 | 76 | 145 |
| 2021 3 | 66 | 39 | 105 |
| 2021 2 | 78 | 37 | 115 |
| 2020 1 | 43 | 28 | 71 |
| 2020 12 | 40 | 28 | 68 |
| 2020 11 | 24 | 24 | 48 |
| 2020 10 | 30 | 23 | 53 |
| 2020 9 | 41 | 18 | 59 |
| 2020 8 | 35 | 28 | 63 |
| 2020 7 | 27 | 14 | 41 |
| 2020 6 | 32 | 35 | 67 |
| 2020 5 | 32 | 10 | 42 |
| 2020 4 | 30 | 21 | 51 |
| 2020 3 | 32 | 29 | 61 |
| 2020 2 | 9 | 0 | 9 |
| 2020 1 | 4 | 0 | 4 |
| 2019 12 | 4 | 0 | 4 |
| 2019 11 | 2 | 0 | 2 |
| 2019 9 | 4 | 0 | 4 |
| 2019 8 | 4 | 0 | 4 |
| 2019 7 | 4 | 0 | 4 |
| 2019 6 | 4 | 0 | 4 |
| 2019 5 | 6 | 0 | 6 |
| 2019 4 | 2 | 3 | 5 |
| 2019 2 | 4 | 0 | 4 |
| 2019 1 | 1 | 2 | 3 |
| 2018 12 | 2 | 0 | 2 |
| 2018 11 | 2 | 0 | 2 |
| 2018 9 | 2 | 0 | 2 |
| 2018 7 | 1 | 0 | 1 |
| 2018 6 | 0 | 1 | 1 |
| 2018 5 | 1 | 0 | 1 |
| 2018 4 | 2 | 0 | 2 |
| 2018 3 | 1 | 0 | 1 |
| 2018 2 | 30 | 2 | 32 |
| 2018 1 | 28 | 7 | 35 |
| 2017 12 | 41 | 15 | 56 |
| 2017 11 | 15 | 11 | 26 |
| 2017 10 | 6 | 9 | 15 |
| 2017 9 | 11 | 10 | 21 |
| 2017 8 | 12 | 10 | 22 |
| 2017 7 | 10 | 15 | 25 |
| 2017 6 | 22 | 15 | 37 |
| 2017 5 | 10 | 25 | 35 |
| 2017 4 | 29 | 28 | 57 |
| 2017 3 | 14 | 37 | 51 |
| 2017 2 | 18 | 51 | 69 |
| 2016 1 | 30 | 75 | 105 |
| 2016 12 | 3 | 26 | 29 |
| 2016 11 | 0 | 23 | 23 |
| 2016 10 | 0 | 30 | 30 |
| 2016 9 | 0 | 2 | 2 |
Mostrar todo
